These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1773784)

  • 1. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
    Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
    Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells.
    Bernstein LR; Bravo R; Colburn NH
    Mol Carcinog; 1992; 6(3):221-9. PubMed ID: 1445622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation.
    Ben-Ari ET; Bernstein LR; Colburn NH
    Mol Carcinog; 1992; 5(1):62-74. PubMed ID: 1543542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
    Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
    Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.
    Amstad PA; Liu H; Ichimiya M; Chang S; Berezesky IK; Trump BF
    Mol Carcinog; 1997 Oct; 20(2):231-9. PubMed ID: 9364213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.
    Hsu TC; Young MR; Cmarik J; Colburn NH
    Free Radic Biol Med; 2000 May; 28(9):1338-48. PubMed ID: 10924853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of an 80-kDa protein kinase C substrate in preneoplastic and neoplastic mouse JB6 cells.
    Simek SL; Kligman D; Patel J; Colburn NH
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7410-4. PubMed ID: 2798414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
    Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
    Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
    Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
    Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.
    Young MR; Li JJ; Rincón M; Flavell RA; Sathyanarayana BK; Hunziker R; Colburn N
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9827-32. PubMed ID: 10449779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.
    Bernstein LR; Colburn NH
    Science; 1989 May; 244(4904):566-9. PubMed ID: 2541502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
    Gu Q; Tan M; Sun Y
    Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.